Reactive haptens are tiny molecules that stimulate an immune response when attached to a protein or other large carrier. Sometimes, the carrier may not stimulate an immune response by itself. Infectious agents, large molecules or insoluble foreign matter can stimulate an immune response in the body. Reactive haptens are used to study immunochemical phenomena, the mechanisms of inflammatory bowel disease and allergic dermatitis contact to induce autoimmune-like responses. Contact allergy is a serious condition which can cause eczema and that can imbalance the quality of life. Rising prevalence of contact allergy increasing the demand for reactive haptens market. Reactive haptens are vastly used in many applications such as microbiology, immunology, toxicology & pharmacology, medicines, immunochemical and many more. Additionally, increase number of patient pool and multiple initiative taken by the government in research and rising investment by the manufacturer in research and development boosting the global reactive haptens market. The key factors such as increasing prevalence of cancer & other diseases and increasing healthcare expenditure boosting the global reactive haptens market.
Rising demand for the advanced treatment options and novel medicines also contributing in the global reactive haptens market growth. Additionally, faster drug approval procedures, increasing adoption rate for therapies with fewer side effects and increasing prevalence of lifestyle diseases are the major growth driving factors for reactive haptens market. However, high investment with a fewer chance of success and high treatment cost and a high attrition rate in the development cycle of the product are the major factors hampering the growth of the reactive haptens market.
The global market for reactive haptens is segmented on basis of applications, end user and geography.
Reactive haptens are considered to be the fastest growing market. Moreover, healthcare insurance is also one of the factors that are expected to raise the reactive haptens market growth during the forecast period. However, lack of awareness among the population and lack of skilled healthcare professionals may restrict the growth of reactive haptens market. Reactive haptens are also widely used to evaluate the properties of specific antibodies and epitopes. Reactive haptens are very important in the production and purification of monoclonal antibodies. They are vitally used in the development of complex qualitative and quantitative immunoassays. All these factors are boosting the growth of reactive haptens market. Based on specificity for haptens, there are two classes of clone inducer have been introduced: conjugate specific and hapten specific. Conjugated specific have large number of reactive haptens cells. Clonal activation requires re-stimulation by the same protein carrier used in vitro selection. Hapten specific only have 2 out of 40 reactive haptens clones. The clones arise much less frequently in hapten specific after immunization.
On the basis of geography, the global reactive haptens market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and the Middle East & Africa. The North America reactive haptens market is expected to register the maximum market share in the global market, followed by Europe, owing to high healthcare and research and development spending and advanced healthcare infrastructure. However, Asia Pacific region is expected to show highest CAGR over the forecast period owing to low manufacturing cost and large patient pool due to high population and is projected to be a lucrative market for present and new emerging market players in the reactive haptens market. However, the market for reactive haptens in Latin America, and the Middle East and Africa regions are estimated to show a stagnant growth over the forecast period owing to poor lifestyle and low spending in research and development.
Examples of some of the key players present in the global reactive haptens market are Chemotechnique MB Diagnostics AB, Creative Biolabs, Thermo Fisher Scientific, Nanoshel, Creative Diagnostics, Sigma-Aldrich, LGC Biosearch Technologies, and others.
The report covers exhaustive analysis on:
Regional analysis includes